Answers are grounded in this paper and cite their sources.
Recent advances in genetic engineering have positioned microalgae such as Chlamydomonas reinhardtii as promising cell factories for synthesis of recombinant products. In this study, C. reinhardtii was cultured under phototrophic mode in a ‘hanging bag’-type photobioreactor with 1.2% CO 2 air and bi-daily feeds of a concentrated medium. After ten days, a biomass density of 2.88 g DCW L −1 was achieved, corresponding to a 3.8-fold increase in biomass productivity compared with batch culture. The fed-batch system was applied to engineered strains of C. reinhardtii expressing transgenes in the chloroplast encoding two different luciferases (LucCP and NLuc) or a fish subunit vaccine (CTB-E2-HA). Although protein levels for CTB-E2-HA and LucCP remained stable throughout fed-batch cultivation, the activity of the latter declined markedly as cultures entered late-log phase. In contrast, both the accumulation and activity of NLuc declined in late log phase. For the vaccine strain, two additional genetic engineering features were incorporated: a codon reassignment strategy was used to ensure transgene biocontainment, and a second gene encoding the bacterial PtxD enzyme was introduced to allow selective growth in phosphite-containing medium, thereby limiting contamination during cultivation. In non-sterile phosphite-based fed-batch cultivation, CTB-E2-HA constituted 0.9% of the total soluble protein of C. reinhardtii . This study underscores the importance of monitoring both recombinant protein yield and activity during cultivation, and of incorporating product quality as a key metric in cultivation process design and optimisation, and highlights the growing biotechnological potential of C. reinhardtii as a cell factory.
No takes yet. Share an insight, caveat, or question.
Cui et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: